+ +

•  

   

     Western blot analysis of Phospho-PKC alpha (T638) in (1) Jurkat lysates treated with TPA; (2) Jurkat lysates using Phospho-PKC alpha (Thr638) antibody.    

  
  

Phospho-PKC alpha (Thr638) antibodies are essential tools for studying the activation and regulatory mechanisms of protein kinase C alpha (PKCα), a member of the serine/threonine-specific PKC family. PKCα plays a critical role in cellular signaling pathways, influencing processes such as proliferation, apoptosis, and differentiation. Its activity is tightly regulated by phosphorylation events and lipid cofactors. The Thr638 residue, located within the kinase domain's activation loop, undergoes phosphorylation during PKCα activation, a step critical for its full enzymatic activity and downstream signaling.

Antibodies targeting phosphorylated Thr638 enable researchers to specifically detect the activated form of PKCα, distinguishing it from its inactive state. These antibodies are widely used in techniques like Western blotting, immunofluorescence, and immunohistochemistry to investigate PKCα activation dynamics in response to stimuli such as growth factors, hormones, or stress signals. Dysregulation of PKCα, including aberrant phosphorylation, has been implicated in cancers, cardiovascular diseases, and neurological disorders, making these antibodies valuable for both basic research and clinical studies. Validation of specificity through knockout controls or phosphatase treatment is recommended to ensure accurate interpretation of results. By tracking PKCα activation status, these antibodies contribute to understanding cellular signaling networks and therapeutic target development.